About
Cognivue is a healthcare technology company focused on digital cognitive assessment tools for early detection of cognitive impairment. The company aims to empower healthcare providers to identify cognitive decline sooner, allowing for early intervention and personalized care plans for patients and caregivers. Cognivue offers FDA-cleared, self-administered computerized cognitive assessment devices that utilize proprietary technology to customize assessments based on individual visual and motor skills. Their main products include the Cognivue Clarity® Device, a comprehensive 10-minute assessment covering four cognitive domains, and the Cognivue Thrive® Device, a quicker 5-minute screening tool. Both devices feature an intuitive interface called the CogniWheel and generate automated reports, making them suitable for various healthcare settings. Cognivue's tools are designed to assist licensed clinicians in evaluating cognitive function, enhancing the sensitivity and standardization of cognitive assessments. The company markets its solutions to a wide range of healthcare providers, including primary care physicians, specialists, and pharmacies, supporting timely detection of cognitive impairment.
Technologies
Keywords
Company Information
-
Employees 33
-
Founded 2018
-
Annual Revenue $4884000
Location
7911 Rae Blvd, Victor, New York, United States, 14564
